PI3 Kinase regulation of neural regeneration and muscle hypertrophy after spinal cord injury

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 3541-3547

  Zhao, Tengfei ^a   Qi, Yiying ^a   Li, Yan ^a   Xu, Kan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Axon regeneration; Muscle atrophy; PI3 Kinase pathway; Spinal cord injury

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; INITIATION FACTOR 4B; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR FOXO;

CELL DIFFERENTIATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; NERVE REGENERATION; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; ANIMAL; ENZYMOLOGY; HYPERTROPHY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

MAMMALIA;

ANIMALS; HUMANS; HYPERTROPHY; MUSCLE, SKELETAL; NERVE REGENERATION; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 84862984631     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1127-1     Document Type: Review

References (72)

1. Dudley GA, Castro MJ, Rogers S, Apple DF Jr (1999) A simple means of increasing muscle size after spinal cord injury: A pilot study. Eur J Appl Physiol Occup Physiol 80:394-396
2. Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C et al (2006) Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20:583-585
3. Lynch GS (2001) Therapies for improving muscle function in neuromuscular disorders. Exerc Sport Sci Rev 29:141-148
4. Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D et al (2005) A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 43:408-416
5. Schwab ME, Bartholdi D (1996) Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319-370
6. Goldberg JL, Klassen MP, Hua Y, Barres BA (2002) Amacrinesignaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296:1860-1864
7. Filbin MT (2006) Recapitulate development to promote axonal regeneration: Good or bad approach? Philos Trans R Soc Lond B Biol Sci 361:1565-1574
8. Fitch MT, Silver J (2008) CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294-301
9. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, Schuman EM (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99:467-472
10. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R et al (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
11. Jaworski J, Sheng M (2006) The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 34:205-219
12. Goswami R, Kilkus J, Dawson SA, Dawson G (1999) Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to proapoptotic stimuli. J Neurosci Res 57:884-893
13. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S (2002) A protein kinase B-dependent and rapamycinsensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99:9213-9218
14. Welsh GI, Stokes CM, Wang X, Sakaue H, Ogawa W, Kasuga M et al (1997) Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Lett 410: 418-422
15. Sun F, He Z (2010) Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol 20:510-518
16. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S et al (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177-189
17. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H et al (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11:895-904
18. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H et al (2002) mTOR interacts with raptor to form anutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163-175
19. Ozcan U, Ozcan L, Yilmaz E, Duvel K, Sahin M, Manning BD et al (2008) Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29:541-551
20. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431-2438
21. Alabed YZ, Pool M, Ong Tone S, Sutherland C, Fournier AE (2010) GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J Neurosci 30:5635-5643
22. Chen W, Chen M, Barak LS (2010) Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: A high-throughput screening approach. Am J Physiol Gastrointest Liver Physiol 299:G293-G300
23. Rhoads RE (1999) Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 274:30337-30340
24. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN et al (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013
25. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808
26. Consortium TECTS (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315
27. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW (1994) Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 91:11477-11481
28. Jeno P, Ballou LM, Novak-Hofer I, Thomas G (1988) Identification and characterization of a mitogen-activated S6 kinase. Proc Natl Acad Sci USA 85:406-410
29. Fingar DC, Blenis J (2004) Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171
30. Jefferies HB, Reinhard C, Kozma SC, Thomas G (1994) Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 91:4441-4445
31. Gingras AC, Raught B, Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev 15:807-826
32. Asante CO, Wallace VC, Dickenson AH (2010) Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat. J Pain 11:1356-1367
33. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B et al (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:963-966
34. Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I et al (2010) PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 13:1075-1081
35. Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW (2010) PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J Neurosci 30:9306-9315
36. Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H et al (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166:213-223
37. Hu LY, Sun ZG, Wen YM, Cheng GZ, Wang SL, Zhao HB et al (2010) ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Neuroscience 169:1046-1062
38. Inoki K, Zhu T, Guan KL (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590
39. Im E, von Lintig FC, Chen J, Zhuang S, Qui W, Chowdhury S et al (2002) Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 21:6356-6365
40. Codeluppi S, Svensson CI, Hefferan MP, Valencia F, Silldorff MD, Oshiro M et al (2009) The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. J Neurosci 29:1093-1104
41. Dann SG, Thomas G (2006) The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett 580:2821-2829
42. Reiling JH, Sabatini DM (2008) Increased mTORC1 signaling UPRegulates stress. Mol Cell 29:533-535
43. Jiang H, Guo W, Liang X, Rao Y (2005) Both the establishment and the maintenance of neuronal polarity require active mechanisms: Critical roles of GSK-3beta and its upstream regulators. Cell 120:123-135
44. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120:137-149
45. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ et al (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793-803
46. Dill J, Wang H, Zhou F, Li S (2008) Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci 28:8914-8928
47. Cyranoski D (2007) Chinese network to start trials of spinal surgery. Nature 446:476-477
48. Kim WY, Zhou FQ, Zhou J, Yokota Y, Wang YM, Yoshimura T et al (2006) Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron 52:981-996
49. Krylova O, Herreros J, Cleverley KE, Ehler E, Henriquez JP, Hughes SM et al (2002) WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons. Neuron 35:1043-1056
50. Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD (2004) NGFinduced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42:897-912
51. Liu M, Bose P, Walter GA, Thompson FJ, Vandenborne K (2008) A longitudinal study of skeletal muscle following spinal cord injury and locomotor training. Spinal Cord 46:488-493
52. Brenes G, Dearwater S, Shapera R, LaPorte RE, Collins E (1986) High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 67:445-450
53. Bauman WA, Spungen AM (2000) Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am 11:109-140
54. Kraus JF, Greenland S (1983) Survival from spinal cord injury. J Chronic Dis 36:297-298
55. Leger B, Senese R, Al-Khodairy AW, Deriaz O, Gobelet C, Giacobino JP et al (2009) Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 40:69-78
56. Dreyer HC, Glynn EL, Lujan HL, Fry CS, DiCarlo SE, Rasmussen BB (2008) Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway. J Appl Physiol 104:27-33
57. Ladner KJ, Caligiuri MA, Guttridge DC (2003) Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278:2294-2303
58. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL et al (2005) TNF-alpha acts via p38 MAPK to stimulate expression of theubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19:362-370
59. Glass DJ (2010) PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol 346:267-278
60. Kimball SR, Farrell PA, Jefferson LS (2002) Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise. J Appl Physiol 93:1168-1180
61. Rochat A, Fernandez A, Vandromme M, Moles JP, Bouschet T, Carnac G et al (2004) Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol Biol Cell 15:4544-4555
62. Kandarian SC, Jackman RW (2006) Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33:155-165
63. Glass DJ (2005) Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37:1974-1984
64. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y et al (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280:2737-2744
65. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO et al (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403
66. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE (2004) Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15:1537-1545
67. Tsuchida K, Nakatani M, Uezumi A, Murakami T, Cui X (2008) Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocr J 55:11-21
68. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L (2003) Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23:7230-7242
69. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258-C1270
70. Hou S, Xu Q, Tian W, Cui F, Cai Q, Ma J et al (2005) The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods 148:60-70
71. Lohmeyer JA, Essmann E, Richerson SJ, Hagel C, Egana JT, Condurache A et al (2008) Use of erythropoietin as adjuvant therapy in nerve reconstruction. Langenbecks Arch Surg 393:317-323
72. Mao X, Zeng X, Wang J, Qiao S (2010) Leucine promotes leptin receptor expression in mouse C2C12 myotubes through the mTOR pathway. Mol Biol Rep 38(5):3201-3206. doi:10.1007/ s11033-010-9992-6